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Abstract 
Background. The effects of sedative and anesthetic agents on sympathetic nerve activity 
(SNA) are poorly understood. 
Objective. To determine the effects of commonly used sedative and anesthetic agents on SNA 
in ambulatory dogs and humans. 
Methods. We implanted radiotransmitters in 6 dogs to record stellate ganglion nerve activity 
(SGNA), subcutaneous nerve activity (ScNA) and blood pressure (BP). After recovery, we 
injected dexmedetomidine (3 µg/kg), morphine (0.1 mg/kg), hydromorphone (0.05 mg/kg) and 
midazolam (0.1 mg/kg) in different days. We also studied 12 human patients (10 males, 
68.0±9.1 years old) undergoing cardioversion for atrial fibrillation with propofol (0.77±0.18 
mg/kg) or methohexital (0.65 mg/kg) anesthesia. Skin sympathetic nerve activity (SKNA) and 
electrocardiogram were recorded during the study. 
Results. SGNA and ScNA were significantly suppressed immediately after administration of 
dexmedetomidine (p=0.000, 0.000), morphine (p=0.011, 0.014) and hydromorphone (p=0.000, 
0.012), along with decreased BP and heart rate (HR) (p<0.001 for each). Midazolam had no 
significant effect on SGNA and ScNA (p=0.248, 0.149). However it increased HR (p=0.015) and 
decreased BP (p=0.004) in ambulatory dogs. In patients undergoing cardioversion, bolus of 
propofol administration significantly suppressed SKNA (from 1.11 ±0.25 µV to 0.77±0.15 µV, 
p=0.001) and the effects lasted for at least 10 min after the final cardioversion shock. 
Methohexital decreased chest SKNA from 1.59±0.45 µV to 1.22±0.58 µV (p=0.000) and arm 
SKNA from 0.76±0.43 µV to 0.55±0.07 µV (p=0.001). The effects lasted for at least 10 min after 
the cardioversion shock. 
Conclusion: Propofol, methohexital, dexmedetomidine, morphine and hydromorphone 
suppressed, but midazolam had no significant effects on SNA. 
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Anesthetic and sedative agents are frequently used during electrophysiological studies. Their 
use may reduce arrhythmia inducibility, increase the need to use isoproterenol or hemodynamic 
support.1-3 While anesthetic agents are known to exert significant effects on synapses and 
axons of mammalian sympathetic ganglia,4 the quantitative effects of anesthetic agents on 
sympathetic nerve activity (SNA) of ambulatory animals or human patients remain unclear. 
Stellate ganglion (SG) is known to be an important source of cardiac sympathetic innervation. 
The SG nerve activity (SGNA) is important in arrhythmogenesis and blood pressure control.5, 6 
The subcutaneous sympathetic nerve activity (ScNA) recorded in ambulatory dogs closely 
correlate with the SGNA.7  Both SGNA and ScNA are associated with spontaneous onset of 
ventricular tachycardia in a canine model.8 Subsequently we developed a new method (neuECG) 
to simultaneously record electrocardiogram (ECG) and superficial skin sympathetic nerve 
activity (SKNA) using conventional ECG patch electrodes in dogs and in humans.9, 10 The 
availability of these recording methods provided us with an opportunity to directly determine the 
effects of anesthetic and sedative agents on SNA. The purpose of the present study was to test 
the hypothesis that commonly used intravenous anesthetic and sedative agents can suppress 
the SNA in normal ambulatory dogs and in humans with atrial fibrillation (AF) undergoing direct 
current cardioversion. 
 
Methods 
Animal experiments were performed with approval of the Institutional Animal Care and Use 
Committee of the Indiana University and conformed to the Guide for the Care and Use of 
Laboratory Animals.  Human studies were performed with approval of the Institutional Review 
Board of the Indiana University. All human subjects gave written informed consent to participate 
in the study. 
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Animal studies 
Surgical preparation  
Six adult mongrel dogs (four males and two females, weighing 25 to 35 kg) underwent sterile 
surgeries with isoflurane inhalation anesthesia. A D70-CCTP radiotransmitter manufactured by 
the Data Sciences International (DSI, St. Paul, MN, USA) was implanted to record left SGNA, 
left thoracic ScNA and the intravascular BP from the descending aorta. The dogs were allowed 
to recover for two weeks before the commencement of baseline ambulatory recording. 
Injection of anesthetic and sedative agents 
All agents were given by single intravenous injection during the daytime. We tested only one 
drug per day to allow complete washout before the next drug was injected. The dosages were 
based those reported in the literature. 1) Dexmedetomidine: dosage for sedation when 
combined with inhalation anesthesia was 2 µg/kg for dogs.11 Based on our experience, 3 µg/kg 
is an effective dose for sedation in dogs when used alone. 2) Morphine: 0.2 mg/kg was used for 
heavy sedation in dogs undergoing thoracic skin incisions.12 However our target was moderate 
sedation and 0.1 mg/kg was adequate. 3) Hydromorphone: 0.05 mg/kg bolus injection was 
selected based on literature.13 4) Midazolam: 0.2 mg/kg was used as co-induction agent for 
dogs.14 We used 0.1 mg/kg injection to achieve medium sedation without depressing respiration. 
The implanted radiotransmitter has a sampling rate limited to 1,000 Hz. Their recordings from 
SG and subcutaneous space was high pass filtered at 150 Hz to display SGNA and ScNA, 
respectively. The same electrical signals from the subcutaneous electrodes were then low pass 
filtered at 100 Hz to display ECG.   
 
Clinical studies 
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We performed an observational study in 12 patients with persistent AF undergoing 
cardioversion as part of their standard care. There were 10 men and 2 women with an average 
age 68.0 ± 9.1 years and an average body mass index of 32.5 ± 7.5 kg/m2. Among them, 11 
were given propofol and 1 was given methohexital prior to cardioversion. We performed two 
channels of neuECG recordings using methods describe in a previous report.9 A pair of bipolar 
electrodes was placed on the left and right subclavian area to simulate the ECG Lead 1. A 
second pair of bipolar electrodes was placed on the right upper arm. ECG and SKNA were 
simultaneously recorded by a ME6000 recorder (Biomation, Almonte, Ontario, Canada) with a 
sampling rate of 10,000/s starting at least 5 min before sedative administration and continued 
until 10 min after cardioversion.  
Statistical Analysis 
The nerve activity recordings were analyzed using custom-written software. For dogs, nerve 
activities were quantified by integrating the absolute value of the filtered signal over 20-s 
windows (iSKNA). The integrated nerve activities were then divided by the total number of 
samples in each window (20,000) to calculate the average SGNA (aSGNA) and average ScNA 
(aScNA). The BP waveforms were analyzed by the software for automatic detection of systolic 
BP (SBP) and diastolic BP (DBP). For clinical studies, the electrical signals were band pass 
filtered from 500-1000 Hz to display nerve activities. The same signals were then band pass 
filtered between 0.5 to 150 Hz to display surface ECG. The aSKNA was the integrated nerve 
activity over 5-s windows divided by 50,000, which is the total number of samples within that 
window. Unless otherwise indicated, all quantitative data are expressed as mean ± standard 
deviation. Paired t-tests were used to compare the means. Repeated measures ANOVA was 
performed individually to compare overall differences among different time points after the 
injection of each agents. Statistical analysis was performed using IBM SPSS Statistics 24 
(SPSS Inc, Chicago, IL, USA). Two-sided p ≤ .05 was considered significant. 
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Results 
Effect of anesthetic/sedative agents on sympathetic nerve activity in dogs 
The dogs became quiet and lied down after all drug injections, but they remained conscious 
without respiratory suppression. Figure 1A shows a typical example of recording showing the 
effects of dexmedetomidine on nerve activity. Dexmedetomidine eliminated all SGNA and most 
ScNA bursts about 2 min after injection. There was a continuous reduction of BP and HR before 
they recovered 20-min later. Figure 1B shows the continuous 28-min mean values of SGNA, 
ScNA, mBP and HR in this same dog. Figure 2 shows the typical effects of morphine (Figure 
2A), hydromorphone (Figure 2B) and midazolam (Figure 2C). Both morphine and 
hydromorphone decreased SGNA and ScNA about 2 min after the injection, along with the 
reduction of BP and HR. The nerve activity, BP and HR recovered about 25 min after injection. 
In comparison, little change of SNA was observed after midazolam injection. Notably midazolam 
injection was transiently followed by decreased BP but increased HR, suggesting that 
baroreflexes were intact immediately after injection. 
Figure 3 summarizes the effects of drugs on all dogs studied. The ordinate shows the 
ratios of SGNA, ScNA, BP and HR to baseline. After injection of dexmedetomidine, SGNA 
decreased to 76±17% of baseline in 2 min (p=0.027) and to a maximum of 41±6% of baseline at 
5 min (p=0.005). ScNA also decreased to 75±12% of baseline in 3-min (p=0.04). That is about 
1-min later than the reduction of SGNA. The maximum reduction was to 58±12% of baseline at 
10 min after injection (p=0.032). The SGNA recovered to 90±16% of baseline at about 25 min 
after injection (p=0.063) while ScNA recovered to 101±13% of baseline at about 30 min after 
injection (p=0.952) (Figure 2A). HR showed parallel reduction to 78±10% of baseline at about 2 
min after injection (p=0.008). BP decreased significantly at about 4 min after injection to 90±7% 
of baseline (p=0.028) (Figure 2E). After morphine injection, the SGNA reduced to 76±17% 
(p=0.046) at 5 min after injection, then partially recovered to 85±15% (p=0.100) at 30 min after 
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injection. ScNA reduced to 79±6% (p=0.001) at 10 min after injection, then partially recovered to 
83±10% (p=0.036) at 30 min after injection (Figure 3B). The SGNA and ScNA after 
hydromorphone injection continued to decline and reached 66±16% (p=0.013) and 71±14% 
(p=0.016) of baseline at 30 min after injection (Figure 3C). Midazolam had no significant effects 
on SGNA or ScNA. At 30 min after injection, the SGNA was 104±15% (p=0.565) of the baseline 
while ScNA was 98±9% (p=0.939) of baseline (Figure 3D). The HR and BP changes paralleled 
the changes of SGNA and ScNA (Figures 3E-H). Dexmedetomidine had the greatest effects on 
the maximal reduction of SGNA (by 40.4±5.4%; p<0.001), ScNA (by 55.7±7.8%; p<0.001), HR 
(by 49.8±5.6%; p<0.001) and mBP (by 69.5±7.3%; p=0.045) among all drugs studied. Repeated 
measures ANOVA was also performed individually to compare overall differences among 
different time points. The F values and p values are shown in each panel. 
Effect of anesthetic/sedative agents on sympathetic nerve activity in humans 
The demographics and clinical characteristics of all 12 patients were shown in Table 1. Figure 4 
shows the effect of propofol on sympathetic nerve activities in a patient who underwent 
cardioversion. Figure 4A shows three 30-s tracings of chest SKNA, arm SKNA, ECG and BP 
before propofol injection, 1 min after propofol injection and after cardioversion. SKNA was 
suppressed after the administration of propofol, but briefly increased by cardioversion in this and 
all patients studied. ECG shows AF before and after propofol injection, and turns to sinus 
rhythm after cardioversion. Figure 4B shows aSKNA and HR over an 18-min period. The black 
dotted lines show the timing of propofol injection (50 mg each time). There was transient 
elevation of SKNA (blue arrows) probably because of pain on propofol injection. That was 
followed by SKN  suppression. Cardioversion (red dotted lines) were followed by large transient 
SKNA elevation (red arrows). Propofol suppressed SKNA for at least 10 min. The average chest 
SKNA at different time point of all 11 patients are shown in Figure 5A. There were large 
differences of baseline SKNA as well as the responses to propofol.  All patients converted to 
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sinus rhythm except one (patient 1) who had a high baseline SKNA that was only briefly 
suppressed by propofol. Of the 11 patients recorded, bolus of propofol administration 
significantly reduced aSKNA from 1.11 ±0.25 µV to 0.89±0.36 µV 5 min after injection (p<0.05) 
and to 0.77±0.14 µV 10 min after injection (p<0.01) (Figure 5B).  
One patient (male, 62 years old) received methohexital (100 mg total) before 
cardioversion. Figure 6 shows the effect of methohexital on SKNA and HR in this patient. Panel 
A shows that methohexital decreased SKNA. Cardioversion shock transiently increased SKNA. 
ECG shows AF before and after methohexital injection, and turns to sinus rhythm after 
cardioversion. Panel B shows a 33-min continuous recording of aSKNA and HR. Methohexital 
injections (50 mg and 30 mg each) are shown by the black lines. Panel C shows the mean 
values of SKNA and HR in different time segments in this patient. Methohexital decreased chest 
aSKNA from 1.59±0.45 µV to 1.22±0.58 µV (p<0.001) and arm aSKNA from 0.76±0.43 µV to 
0.55±0.07 µV (p=0.001). The effects lasted for at least 10 min after the cardioversion shock. 
 
 
Discussion 
We observed in normal ambulatory dogs and humans the effects of widely used 
anesthetic/sedative agents on SNA. Dexmedetomidine and opioids (morphine and 
hydromorphone) significantly suppress the SNA in dogs. Among them, the dexmedetomidine 
seems to have the most profound effects. Propofol and methohexital significantly suppress 
SKNA in humans, but the duration of SKNA suppression varies among different patients. These 
findings indicate that anesthetic/sedative agents commonly used in the electrophysiological 
laboratories have variable effects on the SNA.  
Direct SNA recordings in animal models 
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Monitoring the sympathetic tone using commercially available devices rely on measures such as 
BP and HR, which may provide conflicting information on sympathetic tone during anesthesia.15 
It is highly desirable to develop methods to directly measure the SNA during surgical operation 
or electrophysiological procedures.  We reported that in canine models, the SNA recorded from 
the thoracic skin closely correlates with the SGNA in ambulatory dogs.7 We also showed that 
the SNA recorded with standard ECG patch electrodes (SKNA) can be used to measure 
sympathetic tone in humans.9 However, no data are available to compare the simultaneous 
responses of SGNA and ScNA to anesthetic/sedative agents. The results of the present study 
documented that the SGNA and the ScNA responded similarly to drug administration, 
supporting the use of skin SNA to estimate cardiac sympathetic tone during anesthesia and 
sedation. 
Effects of dexmedetomidine 
Dexmedetomidine, a specific and selective α2 adrenoceptor agonist, reduces SNA to multiple 
tissues and vascular beds.16 Our results confirmed that dexmedetomidine suppresses SNA, HR 
and BP in ambulatory dogs. These results are consistent with previous microneurography 
studies in humans. In that study, the authors used microneurography techniques to show that 
cocaine increased while dexmedetomidine decreased the skin SNA, BP and HR.17 The same 
group of authors also showed that opposite to what was observed in the skin SNA responses, 
the muscle SNA was suppressed by the elevated BP during cocaine administration.18 The 
discrepancies between skin and muscle SNA have also been reported in a study of white coat 
hypertension.19 In the present study, we found that the SKNA and SGNA in ambulatory dogs 
were well correlated and responded similarly to anesthetic agents. Because skin sympathetic 
nerves originate primarily from the ipsilateral SG,20 these data suggest that skin SNA may serve 
as a useful tool in monitor cardiac sympathetic tone during anesthesia and sedation. This 
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information may be helpful in guiding the anesthesia/sedation during electrophysiological 
procedures. 
Effects of opioids and midazolam on SNA in dogs 
Opioid receptors are ubiquitously present in the heart, vasculature, and ganglia. In previous 
studies in dogs, opioid agents decreased HR, BP, norepinephrine and epinephrine plasma 
concentrations due to decreased sympathetic outflow measured by renal SNA.21 However, 
morphine and fentanyl also cause unspecific histamine release–related vasodilatation that 
reduces BP.22 Therefore, reduction of BP after drug administration does not necessary indicate 
a reduction of SNA. In fact, microneurography studies showed no acute effects of fentanyl (a 
potent synthetic opioid) on muscle SNA in humans.23 Chronic mu-opioid receptor stimulation 
markedly decreases the muscle SNA and its response to hypotension.24 However, those studies 
did not measure the skin SNA.  
We were not able to find microneurography studies on midazolam. However, anxiolytic 
therapy with alprazolam (a benzodiazepine) increases muscle SNA and HR not only in patients 
with panic disorder but also in healthy controls.25 In the present study we observed that 
midazolam had no significant effects on sympathetic tone, but slightly decreased BP about 10 
min after intravenous injection. The mechanism of reduction in BP after midazolam may be 
explained by decreased in systemic vascular resistance and myocardial contractility.26  
Effects of propofol and methohexital on human SKNA 
Propofol has significant ion channel effects and has been reported to be both antiarrhythmic and 
proarrhythmic.27 However, its use is associated with a low incidence of ventricular arrhythmias.28 
Propofol inhibits the muscle SNA, HR, BP and decreases the baroreflex sensitivity.29 When 
used to control the pressor response during surgery, the vasodilating effect of propofol overrides 
the neural vasoconstriction induced by surgery, and a further inhibition of the cardiac baroreflex 
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is observed. We were not able to find the effects of propofol on skin SNA in the literature. The 
results of our study indicate that propofol is a potent inhibitor of SKNA although the duration and 
magnitudes of inhibition varied among patients. There is a heterogeneity in the patient cohort. 
Structural heart diseases may be associated with higher basal levels of SNA, resulting in more 
resistance to propofol suppression. Among susceptible patients, the SNA suppression effects 
might prevent the arrhythmia induction during electrophysiological studies.  Methohexital is also 
a muscle SNA inhibitor.30 Only one patient in our study received methohexital. In this patient, 
there was a significant reduction of SKNA and HR and the effects lasted more than 10 min.  
The anti-arrhythmic effects of anesthesia agents 
Anesthesia has been used for temporary arrhythmia control. Thoracic epidural anesthesia can 
be effective for cardiac arrhythmia control and is useful for short-term management of 
ventricular tachycardia storm.31 Selective mu opioid receptor agonists, such as fentanyl or 
morphine, increase the ventricular fibrillation threshold in dogs with coronary artery occlusion.32 
A meta-analysis including 1295 patients in 9 studies concluded that dexmedetomidine is 
associated with a lower incidence of ventricular arrhythmia after elective cardiac surgery.33 
Methohexital minimizes the possibility of potentially life-threatening cardiac arrhythmias during 
electroconvulsive therapy compared with thiamylal or thiopental.34 On the other hand, 
midazolam, which does not suppress SKNA, does not alter the inducibility of reentrant 
tachycardia nor have they shown to affect the sinoatrial node, refractory periods of 
atrioventricular conduction, or accessory pathways.35 We propose that the SNA suppression 
effects might play a role in the mechanism by which anesthetic/sedative agents suppress 
cardiac arrhythmias.  
Implications to clinical and translational research 
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The existing techniques of studying SNA in humans have certain limitations. Heart rate 
variability analyses do not have enough temporal resolution to study the SNA and BP on a beat-
to-beat basis. Microneurography recordings have sufficient temporal resolution to document an 
association between SNA and BP. However, because of the difficulties in maintaining sustained 
impalement, it is impractical to use microneurography techniques for continuous SNA 
monitoring during electrophysiological studies or surgery. We propose that neuECG recordings 
can provide useful information by simultaneously measuring ECG and SKNA during anesthesia 
and sedation. These real time data might be useful in guiding anesthesia during 
electrophysiological procedures. 
Study limitations 
This study is limited by the single dose of each agent used and the lack of information about the 
relative level of sedation achieved by each of those agents. Therefore, the effects of these 
agents on SNA after long term administration remain unknown. In addition, no nociceptive 
stimulus was performed to determine if SNA suppression could be reversed in the presence of 
pain. We did not measure parasympathetic nerve activity during the study. Therefore, the 
effects of these agents on parasympathetic activity remains unknown. 
Conclusions 
We found that dexmedetomidine, morphine and hydromorphone suppressed, while midazolam 
had no significant effects on SGNA and skin SNA in dogs. Propofol and methohexital 
suppresses SKNA in humans. neuECG recordings might be a useful tool in monitoring SNA 
during anesthesia and sedation. 
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Figure 1: Effect of dexmedetomidine on sympathetic nerve activities in one dog. A shows three 
1-min tracings of SGNA, ScNA, ECG, BP and HR on the 2nd, 8th and 20th minute after injection. 
Dexmedetomidine reduced the overall nerve activity within 2 min after injection (the first red 
arrow). There was a reduction of BP and HR, along with increased HR variability. The nerve 
activity, BP and HR recovered to baseline level about 20 min later (the second red arrow). B 
shows a 28-min continuous recording of aSGNA, aScNA, mean arterial BP (mBP) and HR in 
this dog. 0 on the X axis marks the time of dexmedetomidine injection. aSGNA and aScNA 
decreased significantly about 2 min after injection, and recovered towards baseline level about 
20 min later. BP and HR showed a similar trend. 
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Figure 2: The SGNA, ScNA, ECG, BP and HR recordings after injection of morphine (A), 
hydromorphone (B) and midazolam (C) in a typical dog. X axis shows the time after injection in 
minutes. Morphine and hydromorphone decreased both SGNA and ScNA, accompanied with 
the decrease of BP and HR. Midazolam had very little effect on SNA but slightly decreased BP 
and elevated HR immediately after injection (red arrows).  
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Figure 3: Effects of dexmedetomidine, morphine, hydromorphone and midazolam on SNA (A to 
D), BP and HR (E to H) within 30 min after injection. Red, blue, green and purple lines refer to 
SGNA, ScNA, BP and HR, respectively. X axis is the time after injection. Y axis is the ratio 
compared to baseline in each time point. Repeated measures ANOVA was performed 
individually to compare overall differences among different time points. The F values and p 
values are shown in each panel. 
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Figure 4. Effects of propofol on SNA in a patient undergoing cardioversion. A shows 30-s 
tracings of chest SKNA, arm SKNA, ECG and BP before propofol injection, 1 min after propofol 
injection and after cardioversion. Propofol decreased SKNA on both chest and arm leads. ECG 
shows atrial fibrillation (AF) before and after propofol injection, and turns to sinus rhythm after 
cardioversion (red arrow). Note that there was transient elevation of the chest and arm SKNA 
immediately after cardioversion. B shows an 18-min continuous recording of aSKNA and HR. 
SKNA increased shortly (blue arrows) after each dose of propofol injection (50 mg at the black 
dotted lines) because of injection pain. The SKNA then progressively decreased. Cardioversion 
shocks (red line segments) induced large SKNA bursts (red arrows) followed by continued 
quiescence of SKNA. The propofol suppressed SKNA for at least 10 min.  
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Figure 5: Effects of Propofol and cardioversion on average SKNA in all 11 patients. A shows 
average chest SKNA of each patient. Patient 1 did not restore sinus rhythm after cardioversion 
and manifested highest SKNA amongst all. Whether or not the high SKNA contributed to 
cardioversion failure remains unknown. B shows the average level of SKNA in these patients. * 
p<0.05; ** p<0.01 vs. baseline. 
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Figure 6. Effect of methohexital on SKNA in one patient who underwent cardioversion (CV, 
marked by red arrow). A shows 60-s tracings of chest SKNA, arm SKNA, ECG and HR before 
methohexital injection, after injection, immediately after and 10 min after cardioversion. B shows 
a 33-min continuous recording of aSKNA and HR. SKNA decreased after methohexital injection 
(50 and 30 mg each at the time indicated by the black line segments). Cardioversion (red line 
segment) induced large and transient SKNA elevation (blue and orange arrows). C shows the 
mean values of SKNA and HR in different time segments in this patient. ** p<0.01 vs. baseline. 
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Propofol 
(N=11)  
Methohexital 
(N=1) 
Age 68.5 ± 9.3 62.0 
Gender (M/F) 9/2 1/0 
Body weight (kg) 100.1 ± 27.6 153.5 
Body mass index (kg/m2) 31.5 ± 6.8 44.5 
Dosage (mg/kg) 0.77 ± 0.18 0.65 
Persistent atrial fibrillation 7 0 
Paroxysmal atrial fibrillation 3 1 
Atrial flutter 1 0 
Restore to sinus rhythm 10  1  
Previous ablation 7 0 
ICD implanted previously 3 0 
Coronary artery disease 4 0 
Congenital heart defect 1 0 
Sleep apnea 1 1 
 
 
 
